Eli Lilly‘s (NYSE:LLY) Humalog Junior KwikPen insulin lispro injection is available in the U.S. by prescription for people with diabetes, the company said today.
The drug-device combination product is designed as a pre-filled, disposable half-unit insulin pen.
Get the full story at our sister site, Drug Delivery Business News.
The post Eli Lilly’s Humalog Junior KwikPen diabetes drug-device combo launched in U.S. appeared first on MassDevice.
from MassDevice http://ift.tt/2xfz5tx
Cap comentari:
Publica un comentari a l'entrada